251 related articles for article (PubMed ID: 25697071)
21. Effects of cholinesterase inhibitors on postoperative outcomes of older adults with dementia undergoing hip fracture surgery.
Seitz DP; Gill SS; Gruneir A; Austin PC; Anderson G; Reimer CL; Rochon PA
Am J Geriatr Psychiatry; 2011 Sep; 19(9):803-13. PubMed ID: 21873836
[TBL] [Abstract][Full Text] [Related]
22. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.
Tariot PN; Cummings JL; Katz IR; Mintzer J; Perdomo CA; Schwam EM; Whalen E
J Am Geriatr Soc; 2001 Dec; 49(12):1590-9. PubMed ID: 11843990
[TBL] [Abstract][Full Text] [Related]
23. Donepezil-related toxic hepatitis.
Dierckx RI; Vandewoude MF
Acta Clin Belg; 2008; 63(5):339-42. PubMed ID: 19186568
[TBL] [Abstract][Full Text] [Related]
24. Neuroleptic malignant syndrome induced by donepezil.
Matsumoto T; Kawanishi C; Isojima D; Iseki E; Kishida I; Kosaka K
Int J Neuropsychopharmacol; 2004 Mar; 7(1):101-3. PubMed ID: 14731314
[No Abstract] [Full Text] [Related]
25. Combination of risperidone and donepezil in Lewy body dementia.
Geizer M; Ancill RJ
Can J Psychiatry; 1998 May; 43(4):421-2. PubMed ID: 9598283
[No Abstract] [Full Text] [Related]
26. Feasibility of vascular dementia treatment with cholinesterase inhibitors.
Li Y; Meyer JS; Haque MA; Chowdhury MH; Hinh P; Quach M
Int J Geriatr Psychiatry; 2002 Feb; 17(2):194-6. PubMed ID: 11813286
[No Abstract] [Full Text] [Related]
27. [Donepezil as treatment of Charles Bonnet syndrome].
Santos-Bueso E; Serrador-García M; García-Sánchez J
Arch Soc Esp Oftalmol; 2013 Sep; 88(9):369-70. PubMed ID: 23988046
[No Abstract] [Full Text] [Related]
28. [Cholinesterase inhibitors in the treatment of mixed dementia].
Vasenina EE
Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(7 Pt 2):98-103. PubMed ID: 23994939
[TBL] [Abstract][Full Text] [Related]
29. An unusual cardiovascular adverse effect of donepezil.
Celik IE; Acar B; Çay S
Intern Med J; 2015 Aug; 45(8):877-8. PubMed ID: 26220031
[No Abstract] [Full Text] [Related]
30. The long-term efficacy and tolerability of donepezil in patients with vascular dementia.
Wilkinson D; Róman G; Salloway S; Hecker J; Boundy K; Kumar D; Posner H; Schindler R
Int J Geriatr Psychiatry; 2010 Mar; 25(3):305-13. PubMed ID: 19623601
[TBL] [Abstract][Full Text] [Related]
31. Behavioral complications associated with donepezil.
Wengel SP; Roccaforte WH; Burke WJ; Bayer BL; McNeilly DP; Knop D
Am J Psychiatry; 1998 Nov; 155(11):1632-3. PubMed ID: 9812142
[No Abstract] [Full Text] [Related]
32. Tolerability of switching from donepezil to memantine treatment in patients with moderate to severe Alzheimer's disease.
Waldemar G; Hyvärinen M; Josiassen MK; Kørner A; Lehto H; Wetterberg P
Int J Geriatr Psychiatry; 2008 Sep; 23(9):979-81. PubMed ID: 18229874
[No Abstract] [Full Text] [Related]
33. [Post-marketing observational study of donepezil].
Ibach B
Krankenpfl J; 2005; 43(1-3):25. PubMed ID: 15912820
[No Abstract] [Full Text] [Related]
34. Use of memantine for the treatment of dementia.
Lo D; Grossberg GT
Expert Rev Neurother; 2011 Oct; 11(10):1359-70. PubMed ID: 21955192
[TBL] [Abstract][Full Text] [Related]
35. Adverse effects of donepezil in treating Alzheimer's disease associated with Down's syndrome.
Hemingway-Eltomey JM; Lerner AJ
Am J Psychiatry; 1999 Sep; 156(9):1470. PubMed ID: 10484967
[No Abstract] [Full Text] [Related]
36. Donepezil induced antecollis in a patient with Parkinson's disease dementia.
Oh YS; Kim JS; Ryu DW; Lee KS
Neurol Sci; 2013 Sep; 34(9):1685-6. PubMed ID: 23179184
[No Abstract] [Full Text] [Related]
37. Risk of pneumonia in new users of cholinesterase inhibitors for dementia.
Lai EC; Wong MB; Iwata I; Zhang Y; Hsieh CY; Kao Yang YH; Setoguchi S
J Am Geriatr Soc; 2015 May; 63(5):869-76. PubMed ID: 25912671
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of donepezil in patients with dementia with Lewy bodies: preliminary findings from an open-label study.
Mori S; Mori E; Iseki E; Kosaka K
Psychiatry Clin Neurosci; 2006 Apr; 60(2):190-5. PubMed ID: 16594943
[TBL] [Abstract][Full Text] [Related]
39. Effects of Donepezil on Extrapyramidal Symptoms in Patients with Dementia with Lewy Bodies: A Secondary Pooled Analysis of Two Randomized-Controlled and Two Open-Label Long-Term Extension Studies.
Mori E; Ikeda M; Nakagawa M; Miyagishi H; Yamaguchi H; Kosaka K
Dement Geriatr Cogn Disord; 2015; 40(3-4):186-98. PubMed ID: 26226884
[TBL] [Abstract][Full Text] [Related]
40. Pharmacologic treatment expectations in the management of dementia with Lewy bodies.
Kaufer DI
Dement Geriatr Cogn Disord; 2004; 17 Suppl 1():32-9. PubMed ID: 14676467
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
